Boehringer Pradaxa reduces stroke risk in AF patients: RE-LY trial
Pradaxa, an oral anticoagulant, has been approved for the prevention of stroke in AF in more than 50 countries across the globe. RE-LY was a global, Phase III,

Pradaxa, an oral anticoagulant, has been approved for the prevention of stroke in AF in more than 50 countries across the globe. RE-LY was a global, Phase III,

Qutenza (capsaicin) 8% patch is a localised dermal delivery system comprising prescription strength capsaicin. Qutenza is currently FDA approved as a 60-minute application for the management of neuropathic

Acetaminophen and Codeine Phosphate Oral Solution is available in a dose strength of 120mg/12mg per 5mL. Qualitest provides generic pharmaceuticals and supplies them based on total prescriptions filled.

The Natura Guard BP is designed to maintain healthy blood pressure levels which are already within the normal range. Natura Guard comprises of two tripeptides naturally derived from

Revenues decreased by $0.4m, compared to the same period in 2010, primarily due to the timing of purchases by the company’s distribution partners. Research and development (R&D) expenses

The aim of the double-blind, randomized and four-period study was to assess the bronchodilatory effect, pharmacokinetics, safety and tolerability of single inhaled doses of TD-4208 in patients with

The WMS is believed to help CSPC standardize and integrate the warehousing and distribution operations resulting in better efficiency and reduced operating costs. The pharmaceutical company can also

The construction of the new 72,000 ft² facility is slated to finish in 2014. It will allow Boehringer to handle production of active pharmaceutical ingredients used in early

The company’s multi-stage drug delivery technology is based on micron-sized particles of porous silicon particles which protect their payload from several key defenses used by the body and

CTP-499 is an analog of 1-((S)-5-hydroxyhexyl)-3,7-dimethylxanthine (HDX), an active metabolite of pentoxifylline and has a pleiotropic mechanism of action including angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor